Clinical characteristics and evolution of hematological patients and COVID-19 in Argentina: a report from the Argentine Society of Hematology
G Kusminsky, A Basquiera, M García - 2021 - riu.austral.edu.ar
Abstract in English, Spanish Individuals with malignancies and COVID-19 have a lower
survival compared with the general population. However, the information about the impact of …
survival compared with the general population. However, the information about the impact of …
Impaired acute‐phase humoral immunity is the major factor predicting unfavorable outcomes in multiple myeloma patients with SARS‐CoV‐2 Omicron variants …
Z Li, H He, H Li, F Zhang, X Jin, S Liu… - … Journal of Cancer, 2024 - Wiley Online Library
At the end of 2022, a huge tide of SARS‐CoV‐2 infection mainly Omicron BA. 4/5 developed
in China. Multiple myeloma (MM) patients suffered cancer deterioration and mortality from …
in China. Multiple myeloma (MM) patients suffered cancer deterioration and mortality from …
[HTML][HTML] Is COVID‐19 less severe in CML patients than in those with other haematological cancers?
S Claudiani - British Journal of Haematology, 2022 - ncbi.nlm.nih.gov
In addition to age and cardiovascular, respiratory and metabolic comorbidities, cancer has
been found to be associated with worse COVID-19 outcomes. 1 This also applies to …
been found to be associated with worse COVID-19 outcomes. 1 This also applies to …
[HTML][HTML] Supportive care in multiple myeloma: Current practices and advances
TS Miceli, WI Gonsalves, FK Buadi - Cancer treatment and research …, 2021 - Elsevier
Supportive care in multiple myeloma (MM) can have a major impact on quality of life and the
survival outcomes of MM patients. In this review, we will focus on disease and treatment …
survival outcomes of MM patients. In this review, we will focus on disease and treatment …
Delayed diagnosis resulting in increased disease burden in multiple myeloma: the legacy of the COVID-19 pandemic
J Carmichael, F Seymour, G McIlroy, S Tayabali… - Blood Cancer …, 2023 - nature.com
The COVID-19 pandemic has had global healthcare impacts, including high mortality from
SARS-CoV-2 infection in cancer patients; individuals with multiple myeloma (MM) are …
SARS-CoV-2 infection in cancer patients; individuals with multiple myeloma (MM) are …
COVID-19 in multiple myeloma patients: frequencies and risk factors for hospitalization, ventilatory support, intensive care admission and mortality–cooperative …
M Garnica, EDQ Crusoe, G Ribeiro… - … , Transfusion and Cell …, 2024 - SciELO Brasil
Introduction: This study evaluated outcomes and risk factors for COVID-19 in 91 Brazilian
multiple myeloma (MM) patients between April 2020 and January 2022. Results: Of the 91 …
multiple myeloma (MM) patients between April 2020 and January 2022. Results: Of the 91 …
Lymphocytopenia and anti-CD38 directed treatment impact the serological SARS-CoV-2 response after prime boost vaccination in patients with multiple myeloma
S Ghandili, M Schönlein, C Wiessner, H Becher… - Journal of Clinical …, 2021 - mdpi.com
Even though several SARS-CoV-2 vaccines have shown high effectiveness in the
prevention of COVID-19 in healthy subjects, vaccination response in patients with plasma …
prevention of COVID-19 in healthy subjects, vaccination response in patients with plasma …
The ethics of clinical research in the era of COVID-19
JN Vitti, R Vitti, K Chu, S Mellis - Frontiers in Public Health, 2024 - frontiersin.org
There is an urgent need for increased understanding of COVID-19 and strategies for its
prevention, treatment, and mitigation. All participants in the research enterprise, including …
prevention, treatment, and mitigation. All participants in the research enterprise, including …
Humoral response to mRNA-based COVID-19 vaccine and booster effect of a third dose in patients with mature T cell and NK-cell neoplasms
M Kobayashi, A Mori, M Onozawa, S Tsukamoto… - Annals of …, 2023 - Springer
Patients with lymphoid malignancies have impaired humoral immunity caused by the
disease itself and its treatment, placing them at risk for severe coronavirus disease-19 …
disease itself and its treatment, placing them at risk for severe coronavirus disease-19 …
A case of a young multiple myeloma patient with poor prognostic cytogenetics
E Iranijam, S Matin, M Negaresh - Clinical Medicine Insights …, 2023 - journals.sagepub.com
Multiple myeloma is a hematologic malignancy and a subtype of plasma cell dyscrasias,
which accounts for 13% of all hematologic malignancies. It mainly affects older adults and is …
which accounts for 13% of all hematologic malignancies. It mainly affects older adults and is …